SEC Form D private-offering filing

Trellis Bioscience, Inc.

Name: Trellis Bioscience, Inc. - new SEC Form D private-offering filing, Redwood City, CA
Published: 2026-05-15

A new SEC Form D private-offering notice from Redwood City, CA, an undisclosed offering target in Biotech. The source filing is one click away.

Trellis Bioscience, Inc. site↗ Verified via SEC Form D

Biotechnology company developing human monoclonal antibodies derived from the human immune system to treat infectious diseases and cancer.

Filed 2026-05-15Filed to raise UndisclosedFirst money in 2026-01-30Raised so far $6,093,000HQ (as filed) Redwood City, CASector Biotech ✓Stage (inferred) EarlyCall status Late filing

Source linked the Form D on EDGAR↗Website verified trellisbio.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.